U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H23NO4
Molecular Weight 317.3795
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DENOPAMINE

SMILES

COC1=C(OC)C=C(CCNC[C@H](O)C2=CC=C(O)C=C2)C=C1

InChI

InChIKey=VHSBBVZJABQOSG-INIZCTEOSA-N
InChI=1S/C18H23NO4/c1-22-17-8-3-13(11-18(17)23-2)9-10-19-12-16(21)14-4-6-15(20)7-5-14/h3-8,11,16,19-21H,9-10,12H2,1-2H3/t16-/m0/s1

HIDE SMILES / InChI

Molecular Formula C18H23NO4
Molecular Weight 317.3795
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Denopamine is a selective agonist of beta-1 adrenergic receptor. The drug was approved in Japan under the name Kalgut for the treatment of chronic heart failure.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P08588
Gene ID: 153.0
Gene Symbol: ADRB1
Target Organism: Homo sapiens (Human)
7.73 null [pEC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
KALGUT

Approved Use

Chronic heart failure.

Launch Date

1988
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
19.2 ng/mL
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
15.5 ng/mL
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
16.9 ng/mL
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
12.3 ng/mL
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE blood
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
14.2 ng/mL
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE blood
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
11.6 ng/mL
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE blood
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
7.8 ng/mL
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE blood
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
10.7 ng/mL
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE blood
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
10.7 ng/mL
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE blood
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
22.4 ng/mL
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE blood
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
68.3 ng × h/mL
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
57.2 ng × h/mL
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
59.3 ng × h/mL
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
43.6 ng × h/mL
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE blood
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
80.8 ng × h/mL
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE blood
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
72.2 ng × h/mL
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE blood
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
55.6 ng × h/mL
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE blood
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
65.3 ng × h/mL
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE blood
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
65.3 ng × h/mL
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE blood
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
137 ng × h/mL
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE blood
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
4.02 h
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
4 h
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
3.67 h
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
3.6 h
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE blood
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
5 h
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE blood
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
5.4 h
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE blood
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
4 h
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE blood
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
4.5 h
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE blood
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
4.5 h
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE blood
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
4.8 h
10 mg single, oral
dose: 10 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DENOPAMINE blood
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
Funbound

Funbound

ValueDoseCo-administeredAnalytePopulation
57%
DENOPAMINE plasma
Homo sapiens
Doses

Doses

DosePopulationAdverse events​
10 mg 4 times / day multiple, oral
Studied dose
Dose: 10 mg, 4 times / day
Route: oral
Route: multiple
Dose: 10 mg, 4 times / day
Sources:
unhealthy, ADULT
Health Status: unhealthy
Age Group: ADULT
Sex: M+F
Food Status: UNKNOWN
Sources:
PubMed

PubMed

TitleDatePubMed
Binding pockets of the beta(1)- and beta(2)-adrenergic receptors for subtype-selective agonists.
1999-11
Cellular characterization of the pharmacological selectivity and tachyphylactic properties of denopamine for the human beta adrenergic receptors.
1993-11
Beta 1-adrenergic selectivity of the new cardiotonic agent denopamine in its stimulating effects on adenylate cyclase.
1987-06-15
Cardiovascular effects of the new positive inotropic agent denopamine with special reference to species difference and the effect on failing heart.
1986-07
Metabolic fate of the new cardiotonic denopamine in animals. 4th communication: effects of coadministered drugs on the plasma concentration and metabolism of denopamine in dogs.
1986-04
Metabolic fate of the new cardiotonic denopamine in animals. 2nd communication: tissue accumulation in the rat after consecutive oral administration of 14C-denopamine.
1986-04
In vitro metabolism of the new cardiotonic agent denopamine (TA-064) by rat and rabbit liver preparations. Oxidation, methylation, and glucuronidation.
1985-03-01
Relationship between positive inotropic action and blood levels of denopamine in cats.
1985
Cardiovascular effects of a new positive inotropic agent, (-)-(R)-1-(p-hydroxyphenyl)-2-[(3,4-dimethoxyphenethyl)amino]-ethanol (TA-064) in the anesthetized dog and isolated guinea pig heart.
1984-08
Patents

Sample Use Guides

15-30 mg are administered orally in three divided doses.
Route of Administration: Oral
The effects of denopamine on the L-type Ca2+ current (ICa) were examined in rabbit ventricular cells. Denopamine stimulated basal ICa with a maximum response of +33.2% and a concentration for half-maximal response (EC50) of 0.039 uM. The maximun response of ICa was only a quarter of that induced by isoprenaline (ISO), while 10 uM denopamine elicited 70–75% of the maximum inotropic response in the papillary muscle preparations.
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:18:00 GMT 2025
Edited
by admin
on Mon Mar 31 18:18:00 GMT 2025
Record UNII
V5F60UPD8P
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DENOPAMINE
INN   JAN   MART.   MI   WHO-DD  
INN  
Official Name English
KALGUT
Preferred Name English
TA-064
Code English
DENOPAMINE [JAN]
Common Name English
Denopamine [WHO-DD]
Common Name English
(-)-(R)-.ALPHA.-(((3,4-DIMETHOXYPHENETHYL)AMINO)METHYL)-P-HYDROXYBENZYL ALCOHOL
Common Name English
TA 064
Code English
denopamine [INN]
Common Name English
DENOPAMINE [MART.]
Common Name English
DENOPAMINE [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C48149
Created by admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
Code System Code Type Description
INN
5460
Created by admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
PRIMARY
CAS
71771-90-9
Created by admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
PRIMARY
NCI_THESAURUS
C77934
Created by admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
PRIMARY
MESH
C037293
Created by admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
PRIMARY
WIKIPEDIA
Denopamine
Created by admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
PRIMARY
ChEMBL
CHEMBL493682
Created by admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
PRIMARY
DRUG CENTRAL
806
Created by admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
PRIMARY
SMS_ID
100000083180
Created by admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
PRIMARY
EVMPD
SUB06977MIG
Created by admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
PRIMARY
MERCK INDEX
m4166
Created by admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
PRIMARY Merck Index
FDA UNII
V5F60UPD8P
Created by admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
PRIMARY
EPA CompTox
DTXSID8045800
Created by admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
PRIMARY
PUBCHEM
5311064
Created by admin on Mon Mar 31 18:18:00 GMT 2025 , Edited by admin on Mon Mar 31 18:18:00 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> AGONIST
METABOLIC ENZYME -> SUBSTRATE
Related Record Type Details
METABOLITE -> PARENT
MAJOR
URINE
METABOLITE -> PARENT
MAJOR
URINE
METABOLITE -> PARENT
MINOR
URINE
METABOLITE -> PARENT
URINE
METABOLITE -> PARENT
MINOR
URINE
Related Record Type Details
ACTIVE MOIETY